<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Zinc sulfate: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Zinc sulfate: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Zinc sulfate: Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="10328" href="/d/html/10328.html" rel="external">see "Zinc sulfate: Drug information"</a> and <a class="drug drug_patient" data-topicid="12159" href="/d/html/12159.html" rel="external">see "Zinc sulfate: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F235812"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Orazinc [OTC];</li>
<li>Zinc 15 [OTC];</li>
<li>Zinc-220 [OTC] [DSC]</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52868637"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Micro-Zn</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F1043062"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Mineral, Oral</span>;</li>
<li>
<span class="list-set-name">Mineral, Parenteral</span>;</li>
<li>
<span class="list-set-name">Trace Element</span></li></ul></div>
<div class="block don drugH1Div" id="F53462626"><span class="drugH1">Dosing: Neonatal</span>
<p style="text-indent:0em;display:inline">
<b>Note: </b>Dosage expressed in terms of <b>elemental</b> zinc.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Adequate intake (AI): Note:</b> Recommended intake from dietary sources (eg, breast milk, formula).</p>
<p style="text-indent:-2em;margin-left:4em;">Neonates: Oral: 2 mg <b>elemental </b>zinc/day (IOM 2001; NIH 2022).</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="3e9cdd60-f47f-4fe0-bbeb-8e9f26c8d5ff">Parenteral nutrition, maintenance zinc requirement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Parenteral nutrition, maintenance zinc requirement:</b> Higher doses than those shown may be needed if impaired intestinal absorption or an excessive loss of zinc (eg, excessive, prolonged diarrhea; high-output intestinal fistula; burns) (AAP [Kleinman 2019]).</p>
<p style="text-indent:-2em;margin-left:4em;">Preterm and term neonates:</p>
<p style="text-indent:-2em;margin-left:6em;">&lt;3 kg: IV: 400 to 500 mcg <b>elemental</b> zinc/kg/day as an additive to parenteral nutrition solution (ASPEN 2020; ASPEN [Corkins 2015]; ESPEN/ESPR/CSPEN [Domellöf 2018]).</p>
<p style="text-indent:-2em;margin-left:6em;">≥3 kg: Usual dose: IV: 250 mcg <b>elemental </b>zinc/kg/day as an additive to parenteral nutrition solution (ASPEN 2020; ESPEN/ESPR/CSPEN [Domellöf 2018]); reported range: 50 to 250 mcg<b> elemental</b> zinc/kg/day (ASPEN [Corkins 2015]; ASPEN [Mirtallo 2004]).</p></div>
</div>
</div>
<div class="block dop drugH1Div" id="F235816"><span class="drugH1">Dosing: Pediatric</span>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Dosages may be presented in units of mcg or <b>mg</b>; use caution to ensure correct units.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="3e9cdd60-f47f-4fe0-bbeb-8e9f26c8d5ff">Parenteral nutrition, maintenance zinc requirement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Parenteral nutrition, maintenance zinc requirement: Note: </b>Higher doses may be needed (in some cases between 2 to 3 times the maintenance requirement) if impaired intestinal absorption or an excessive loss of zinc (eg, excessive, prolonged diarrhea; high-output intestinal fistula; burns) (AAP [Kleinman 2019]).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>ASPEN recommendations: </i>Infants, Children, and Adolescents:</p>
<p style="text-indent:-2em;margin-left:6em;">3 to &lt;10 kg: IV: Usual dose: 250 mcg <b>elemental </b>zinc/kg/day as an additive to parenteral nutrition solution (ASPEN 2020); reported range: 50 to 250 mcg<b> elemental</b> zinc/kg/day (ASPEN [Corkins 2015]; ASPEN [Mirtallo 2004]).</p>
<p style="text-indent:-2em;margin-left:6em;">10 to 40 kg: IV: Usual dose: 50 mcg <b>elemental </b>zinc/kg/day as an additive to parenteral nutrition solution (ASPEN 2020); reported range: 50 to 125 mcg<b> elemental</b> zinc/kg/day; maximum daily dose: 5,000 mcg<b> elemental </b>zinc<b>/day</b> (ASPEN [Corkins 2015]; ASPEN [Mirtallo 2004]).</p>
<p style="text-indent:-2em;margin-left:6em;">&gt;40 kg: IV: 2,000 to 5,000 mcg <b>elemental</b> zinc/day as an additive to parenteral nutrition solution.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>ESPGHAN recommendations: </i>Infants, Children, and Adolescents:</p>
<p style="text-indent:-2em;margin-left:6em;">Infants &lt;3 months: IV: 250 mcg <b>elemental</b> zinc/kg/day as an additive to parenteral nutrition solution (ESPEN/ESPR/CSPEN [Domellöf 2018]).</p>
<p style="text-indent:-2em;margin-left:6em;">Infants ≥3 months: IV: 100 mcg <b>elemental</b> zinc/kg/day as an additive to parenteral nutrition solution (ESPEN/ESPR/CSPEN [Domellöf 2018]).</p>
<p style="text-indent:-2em;margin-left:6em;">Children and Adolescents: IV: 50 mcg <b>elemental</b> zinc/kg/day as an additive to parenteral nutrition solution; maximum daily dose: 5,000 mcg <b>elemental</b> zinc/<b>day</b> (ESPEN/ESPR/CSPEN [Domellöf 2018]).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="f3480f9a-15dc-465d-a061-6aa1eb4b726a">Diarrhea, treatment; malnourished patient</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Diarrhea, treatment; malnourished patient:</b> Limited data available (WHO/UNICEF 2004): <b>Note: </b> Zinc should be started in conjunction with oral rehydration solutions at first sign of diarrhea; zinc therapy may shorten the duration and severity of episodes and prevent subsequent episodes (Bhandari 2008; Lazzerini 2016; Lukacik 2008; WHO/UNICEF 2004).</p>
<p style="text-indent:-2em;margin-left:4em;">Infants &lt;6 months: Oral: 10 <b>mg</b>
<b>elemental</b> zinc once daily for 10 to 14 days (Bhandari 2008; Trivedi 2009; WHO/UNICEF 2004).</p>
<p style="text-indent:-2em;margin-left:4em;">Infants ≥6 months and Children: Oral: 20 <b>mg elemental</b> zinc once daily for 10 to 14 days (Bhandari 2008; Trivedi 2009; WHO/UNICEF 2004). <b>Note:</b> Lower doses of 5 <b>mg </b>or 10 <b>mg</b> once daily for 14 days have shown noninferior efficacy and have been associated with less vomiting (Dhingra 2020).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="e3394963-0383-45f6-b18d-7e9587b80a50">Zinc deficiency; treatment</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Zinc deficiency; treatment: </b>Limited data available:</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Acquired (eg, secondary to cystic fibrosis, liver disease, sickle cell disease, short-bowel syndrome, intestinal failure):</i> Infants, Children, and Adolescents: Oral: 0.5 to 2 <b>mg elemental</b> zinc/kg/day (AAP 1978; AAP [Kleinman 2019]; ASPEN [Corkins 2015]); dose should be individualized; required dose dependent upon multiple factors, which may include the following: age (younger patients, especially infants, have higher requirements), underlying cause of deficiency, physiologic status of other trace elements, enteral/parenteral nutrition intake (Borowitz 2002; Hotz 2001; Ubesie 2013).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Acrodermatitis enteropathica:</i> Infants, Children, and Adolescents: Oral: 3 <b>mg elemental</b> zinc/kg/day; duration of therapy is typically life-long (Joyce 2020).</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F52415638"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; however, zinc and aluminum accumulation may occur in the setting of renal impairment.</p></div>
<div class="block dohp drugH1Div" id="F52415639"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doa drugH1Div" id="F235814"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="10328" href="/d/html/10328.html" rel="external">see "Zinc sulfate: Drug information"</a>)</p>
<p style="text-indent:0em;display:inline">
<b>Note: Dosing units: </b>All dosages are expressed as elemental zinc unless stated otherwise. Oral zinc sulfate contains ~23% elemental zinc.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="81863c66-ac4f-45ff-b638-ded564c6efe2">Dietary supplement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Dietary supplement:</b>
<b>Oral:</b> 50 mg once daily.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c6ddc184-6e5a-4727-9f62-02484be5592f">Parenteral nutrition additive, maintenance requirement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Parenteral nutrition additive, maintenance requirement: </b>
<b>Note:</b> Individualize dose based on the patient's clinical condition, nutritional requirements, and the contribution of oral or enteral zinc intake.</p>
<p style="text-indent:-2em;margin-left:4em;">Acute metabolic states: <b>IV: </b>Optimal dose not determined; monitor and replace as clinically indicated. Expert consensus recommendation suggest: 2.5 to 6.5 mg/day (Blaauw 2019).</p>
<p style="text-indent:-2em;margin-left:4em;">Metabolically stable: <b>IV:</b> 3 to 5 mg/day (ASPEN 2020).</p>
<p style="text-indent:-2em;margin-left:4em;">Replacement for small bowel fluid loss (metabolically stable): <b>IV:</b> Additional zinc replacement may be required for patients with high-output intestinal fistula, ostomy effluent, or severe diarrhea due to excessive zinc loss. Estimated loss ranges from up to an additional 12 mg zinc per L for small bowel fluid loss or an additional ~17 mg zinc per kg of stool or ileostomy output (Blaauw 2019; Jeejeebhoy 2009; Vanek 2012; manufacturer's labeling).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="8b4ba772-3e4e-4d21-b2ed-31570666d4cb">Zinc deficiency</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Zinc deficiency:</b>
<b>Oral:</b> Optimal dose not determined; some recommend daily doses of 2 to 3 times the zinc RDA for mild deficiency and 4 to 5 times the RDA for moderate to severe deficiency for 6 months (Saper 2009).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F57848309"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; however, zinc and aluminum accumulation may occur in the setting of renal impairment.</p></div>
<div class="block doha drugH1Div" id="F57848310"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F235798"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">There are no adverse reactions listed in the manufacturer's labeling.</p></div>
<div class="block coi drugH1Div" id="F13881522"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;">Injection: Hypersensitivity to zinc or any component of the formulation.</p></div>
<div class="block war drugH1Div" id="F13881523"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Renal impairment: Use with caution in patients with renal impairment.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concurrent drug therapy issues:</i></b></p>
<p style="text-indent:-4em;margin-left:6em;">• Copper: Chronic administration of high-dose zinc may cause a decrease in enteral copper absorption and subsequent decreased copper deficiency (Kumar 2022; Marumo 2021; manufacturer's labeling).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Aluminum: The parenteral product may contain aluminum; toxic aluminum concentrations may be seen with high doses, prolonged use, or renal dysfunction. Premature neonates are at higher risk due to immature renal function and aluminum intake from other parenteral sources. Parenteral aluminum exposure of &gt;4 to 5 mcg/kg/day is associated with CNS and bone toxicity; tissue loading may occur at lower doses (Federal Register 2002).</p></div>
<div class="block dosfc drugH1Div" id="F21963760"><span class="drugH1">Dosage Forms Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">Strength of zinc sulfate injection is expressed as elemental zinc</p>
<p style="text-indent:-2em;margin-left:2em;">Oral zinc sulfate is approximately 23% elemental zinc</p></div>
<div class="block foc drugH1Div" id="F235804"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Capsule, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Orazinc: 220 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Zinc-220: 220 mg [DSC]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 220 mg</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1 mg/mL (10 mL); 3 mg/mL (10 mL); 5 mg/mL (5 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1 mg/mL (10 mL); 3 mg/mL (10 mL); 5 mg/mL (5 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Orazinc: 110 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Zinc 15: 66 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 220 mg</p></div>
<div class="block geq drugH1Div" id="F235793"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F235807"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Capsules</b> (Orazinc Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">220 (50 Zn) mg (per each): $0.08</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Capsules</b> (Zinc Sulfate Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">220 (50 Zn) mg (per each): $0.23</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Zinc Sulfate Intravenous)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1 mg/mL (per mL): $1.68 - $3.68</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">3 mg/mL (per mL): $5.04 - $11.07</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">5 mg/mL (per mL): $8.40 - $18.42</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Orazinc Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">110 mg (per each): $0.04</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Zinc 15 Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">66 mg (per each): $0.02</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Zinc Sulfate Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">220 (50 Zn) mg (per each): $0.04</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52868638"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Micro-Zn: 1 mg/mL (10 mL); 5 mg/mL (10 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 5 mg/mL (5 mL)</p></div>
<div class="block admp drugH1Div" id="F52614031"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:-2em;margin-left:2em;">Oral: Administer with food if GI upset occurs.</p>
<p style="text-indent:-2em;margin-left:2em;">Parenteral: IV: Not for direct IV infusion; must be prepared and used as an admixture in parenteral nutrition solutions only.</p></div>
<div class="block adm drugH1Div" id="F53601592"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>IV:</b> Not for direct IV infusion; acidic pH of the solution may cause vein irritation, phlebitis, damage, or thrombosis; must be prepared and used as an admixture in parenteral nutrition solutions only.</p></div>
<div class="block sts drugH1Div" id="F3149579"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:-2em;margin-left:2em;">Capsule: Store at 15°C to 30°C (59°F to 86°F).</p>
<p style="text-indent:-2em;margin-left:2em;">Tablet: Store at 13°C to 24°C (55°F to 76°F).</p>
<p style="text-indent:-2em;margin-left:2em;">Injection: Store intact vials at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Use parenteral nutrition containing zinc sulfate promptly after mixing (limit up to 4 hours at room temperature after container has been penetrated) or may store admixed solution for up to 9 days at 2°C to 8°C (36°F to 46°F); after removal from refrigeration, use promptly and complete infusion within 24 hours. Protect the admixed solution from light.</p></div>
<div class="block usep drugH1Div" id="F53569530"><span class="drugH1">Use</span>
<p style="text-indent:-2em;margin-left:2em;">Oral: Dietary supplementation of zinc (dietary supplement; consult product-specific labeling for manufacturer recommended ages); has also been used to help reduce the duration and severity of diarrhea in malnourished patients.</p>
<p style="text-indent:-2em;margin-left:2em;">Parenteral: Prevention of zinc deficiency as an additive to parenteral nutrition (FDA approved in all ages).</p></div>
<div class="block mst drugH1Div" id="F554161"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues: </span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">ZnSO<sub>4</sub> is an error-prone abbreviation (mistaken as  morphine sulfate)</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13300239"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F6223740"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Baloxavir Marboxil: Polyvalent Cation Containing Products may decrease the serum concentration of Baloxavir Marboxil. <i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Bictegravir: Polyvalent Cation Containing Products may decrease the serum concentration of Bictegravir.  Management: Administer bictegravir under fasting conditions at least 2 hours before or 6 hours after polyvalent cation containing products. Coadministration of bictegravir with or 2 hours after most polyvalent cation products is not recommended.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Bisphosphonate Derivatives: Polyvalent Cation Containing Products may decrease the serum concentration of Bisphosphonate Derivatives.  Management: Avoid administration of oral medications containing polyvalent cations within: 2 hours before or after tiludronate/clodronate/etidronate; 60 minutes after oral ibandronate; or 30 minutes after alendronate/risedronate.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Cabotegravir: Polyvalent Cation Containing Products may decrease the serum concentration of Cabotegravir.  Management: Administer polyvalent cation containing products at least 2 hours before or 4 hours after oral cabotegravir.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Deferiprone: Polyvalent Cation Containing Products may decrease the serum concentration of Deferiprone.  Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Dolutegravir: Zinc Salts may decrease the serum concentration of Dolutegravir.  Management: Administer dolutegravir at least 2 hours before or 6 hours after oral zinc salts. Administer the dolutegravir/rilpivirine combination product at least 4 hours before or 6 hours after oral zinc salts.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Eltrombopag: Polyvalent Cation Containing Products may decrease the serum concentration of Eltrombopag.  Management: Administer eltrombopag at least 2 hours before or 4 hours after oral administration of any polyvalent cation containing product.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Elvitegravir: Polyvalent Cation Containing Products may decrease the serum concentration of Elvitegravir.  Management: Administer elvitegravir 2 hours before or 6 hours after the administration of polyvalent cation containing products.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Levonadifloxacin: Zinc Salts may decrease the serum concentration of Levonadifloxacin. <i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">PenicillAMINE: Polyvalent Cation Containing Products may decrease the serum concentration of PenicillAMINE.  Management: Separate the administration of penicillamine and oral polyvalent cation containing products by at least 1 hour.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Quinolones: Zinc Salts may decrease the serum concentration of Quinolones.  Management: Give oral quinolones at several hours before (4 h for moxi- and sparfloxacin, 2 h for others) or after (8 h for moxi-, 6 h for cipro/dela-, 4 h for lome-, 3 h for gemi-, and 2 h for enox-, levo-, nor-, pe- or ofloxacin or nalidixic acid) oral zinc salts.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Raltegravir: Polyvalent Cation Containing Products may decrease the serum concentration of Raltegravir.  Management: Administer raltegravir 2 hours before or 6 hours after administration of the polyvalent cations. Dose separation may not adequately minimize the significance of this interaction.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Roxadustat: Polyvalent Cation Containing Products may decrease the serum concentration of Roxadustat.  Management: Administer roxadustat at least 1 hour after the administration of oral polyvalent cation containing products.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Tetracyclines: Zinc Salts may decrease the absorption of Tetracyclines. Only a concern when both products are administered orally.  Management: Separate administration of oral tetracycline derivatives and oral zinc salts by at least 2 hours to minimize this interaction.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Trientine: Polyvalent Cation Containing Products may decrease the serum concentration of Trientine.  Management: Avoid concomitant use of trientine and polyvalent cations. If oral iron supplements are required, separate the administration by 2 hours. For other oral polyvalent cations, give trientine 1 hour before, or 1 to 2 hours after the polyvalent cation.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Unithiol: May diminish the therapeutic effect of Polyvalent Cation Containing Products.<i> Risk X: Avoid combination</i></p></div>
<div class="block foi drugH1Div" id="F235811"><span class="drugH1">Food Interactions</span>
<p style="text-indent:0em;display:inline">Avoid foods high in calcium or phosphorus.</p></div>
<div class="block dic drugH1Div" id="F235808"><span class="drugH1">Dietary Considerations</span>
<p style="text-indent:0em;display:inline">May be taken with food if GI upset occurs.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dietary reference intake </b>
<b>(IOM 2001):</b></p>
<p style="text-indent:-2em;margin-left:4em;">1 to 6 months: Adequate intake (AI): 2 mg <b>elemental </b>zinc/day.</p>
<p style="text-indent:-2em;margin-left:4em;">7 to 12 months: Recommended dietary allowance (RDA): 3 mg <b>elemental</b> zinc/day.</p>
<p style="text-indent:-2em;margin-left:4em;">1 to 3 years: RDA: 3 mg <b>elemental </b>zinc/day.</p>
<p style="text-indent:-2em;margin-left:4em;">4 to 8 years: RDA: 5 mg<b> elemental </b>zinc/day.</p>
<p style="text-indent:-2em;margin-left:4em;">9 to 13 years: RDA: 8 mg <b>elemental </b>zinc/day.</p>
<p style="text-indent:-2em;margin-left:4em;">14 to 18 years: RDA:</p>
<p style="text-indent:-2em;margin-left:6em;">Females: 9 mg<b> elemental </b>zinc/day.</p>
<p style="text-indent:-2em;margin-left:6em;">Males: 11 mg <b>elemental </b>zinc/day.</p>
<p style="text-indent:-2em;margin-left:6em;">Pregnancy: 12 mg <b>elemental </b>zinc/day.</p>
<p style="text-indent:-2em;margin-left:6em;">Lactation: 13 mg <b>elemental </b>zinc/day.</p>
<p style="text-indent:-2em;margin-left:4em;">Adults ≥19 years: RDA:</p>
<p style="text-indent:-2em;margin-left:6em;">Females: 8 mg <b>elemental </b>zinc/day.</p>
<p style="text-indent:-2em;margin-left:6em;">Males: 11 mg <b>elemental </b>zinc/day.</p>
<p style="text-indent:-2em;margin-left:6em;">Pregnancy: 11 mg <b>elemental </b>zinc/day.</p>
<p style="text-indent:-2em;margin-left:6em;">Lactation: 12 mg<b> elemental </b>zinc/day.</p></div>
<div class="block pri drugH1Div" id="F13881520"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Zinc crosses the placenta and can be measured in the cord blood and placenta. Fetal concentrations are regulated by the placenta (de Moraes 2011).</p></div>
<div class="block mopp drugH1Div" id="F53569523"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Patients on parenteral nutrition or long-term therapy should have periodic serum copper and serum zinc levels (typically every 3 months suggested) (AAP [Kleinman 2019]; ASPEN [Corkins 2015]); alkaline phosphatase, taste acuity, mental depression; for<i> Acrodermatitis enteropathica, </i>monitor plasma zinc levels every 3 to 6 months (Joyce 2020).</p></div>
<div class="block phk drugH1Div" id="F46169264"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Absorption: pH-dependent; enhanced at lower pH; (pH &lt;3); impaired by food (Anderson 1998).</p>
<p style="text-indent:-2em;margin-left:2em;">Distribution: Stored primarily in skeletal muscle and bone (IOM 2001).</p>
<p style="text-indent:-2em;margin-left:2em;">Protein binding: Albumin and alpha 1-macroglobulin (Foote 1984).</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Feces and urine (IOM 2001).</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F2869420"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Zinc | Zincaps</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Imuzin | Mazic | Nid | Oral z | Oralzin | Orazinc | P zink | Pep | Xinadal | Xinc | Zedex | Ziflu | Zinc R | Zincare | Zt</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Zincteral | Zinek</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Multivit zinco | Unizinco | Zinco | Zinco zn | Zincopan | Zinctrace</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Collazin</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Fortzink | Zinc O | Zinkids</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Zinci sulfurici | Zincteral</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Vegan zink | Zink | Zinkit | Zinksul</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Fortzink</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Fortzink</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Octozinc | Solvazinc | Zinc</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Z span | Zincomed</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Solvazinc</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Egozinc | Zincaps</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Zincomed</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Avazinc | Zincol</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Actizinc | Ascazin | Immugard | Ulseel | Zia | Zincolak | Zinfate | Zynwin</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Zedex</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Zeenk | Zs</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Finezinc | Gczinc | Jeil zinc balance | Zinc line | Zinc s | Zincon | Zinga</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Zinco</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Zinc | Zincteral | Zinek</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Zincteral</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Bonsulfar | Zn-fusin</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Ascazin</span>;</li>
<li>
<span class="countryCode">(NG)</span> <span class="country">Nigeria</span><span class="countrySeparator">: </span><span class="drugName">Archy zinc sulphate | Goldmoore baby zinc | Qualihealth zinc sulphate</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Zincaps</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Fortzink</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Prozinc</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Oezi | Zinc sulphate | Zincare | Zink | Zisul | Zynq</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Zincteral</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Zinc 220 | Zincate</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Zincteral | Zinkit</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Zincteral</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Zinc | Zinccaps | Zincpose | Zinctab</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Aprivex cinko | Berazinc | Nutraxin vitals zinc | Zinco | Zinxx</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Zincteral</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Zinc Promofarma</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Sulfato de zinc</span>;</li>
<li>
<span class="countryCode">(ZW)</span> <span class="country">Zimbabwe</span><span class="countrySeparator">: </span><span class="drugName">Zincol</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Aluminum in large and small volume parenterals used in total parenteral nutrition. <i>Fed Regist</i>. 2002;67(244):77792-77793. To be codified at 21 CFR §201.323.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-704215">
<a name="704215"></a>American Academy of Pediatrics Committee on Nutrition. Zinc. <i>Pediatrics</i>. 1978;62(3):408-412.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/704215/pubmed" id="704215" target="_blank">704215</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  American Academy of Pediatrics Committee on Nutrition. Kleinman RE, Greer FR, eds. <i>Pediatric Nutrition Handbook</i>. 8th ed. Itasca, IL: American Academy of Pediatrics; 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ABIM.1">
<a name="ABIM.1"></a>American Board of Internal Medicine (ABIM). Laboratory test reference ranges, 2023. https://www.abim.org/Media/bfijryql/laboratory-reference-ranges.pdf. Updated July 2023. Accessed December 6, 2023.</div>
</li>
<li>
<div class="reference">
                  American Society for Parenteral and Enteral Nutrition (ASPEN). Appropriate dosing for parenteral nutrition: ASPEN recommendations. Updated November 17, 2020. Accessed November 29, 2022. https://www.nutritioncare.org/uploadedFiles/Documents/Guidelines_and_Clinical_Resources/PN%20Dosing%201-Sheet-Nov%202020-FINAL.pdf
                  </div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9475826">
<a name="9475826"></a>Anderson LA, Hakojarvi SL, Boudreaux SK. Zinc acetate treatment in Wilson's disease. <i>Ann Pharmacother</i>. 1998;32(1):78-87.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/9475826/pubmed" id="9475826" target="_blank">9475826</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18450870">
<a name="18450870"></a>Bhandari N, Mazumder S, Taneja S, et al. Effectiveness of zinc supplementation plus oral rehydration salts compared with oral rehydration salts alone as a treatment for acute diarrhea in a primary care setting: a cluster randomized trial. <i>Pediatrics</i>. 2008;121(5):e1279-e1285.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/18450870/pubmed" id="18450870" target="_blank">18450870</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30812055">
<a name="30812055"></a>Blaauw R, Osland E, Sriram K, et al. Parenteral provision of micronutrients to adult patients: an expert consensus paper. <i>JPEN J Parenter Enteral Nutr</i>. 2019;43 (suppl 1):S5-S23. doi: 10.1002/jpen.1525.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/30812055/pubmed" id="30812055" target="_blank">30812055</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12352509">
<a name="12352509"></a>Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. <i>J Pediatr Gastroenterol Nutr</i>. 2002;35(3):246-259.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/12352509/pubmed" id="12352509" target="_blank">12352509</a>]</span>
</div>
</li>
<li>
<div class="reference">
<i>Clinical Management of Acute Diarrhoea</i>, Geneva, NY: World Health Organization/UNICEF, 2004. Available at http://www.unicef.org/nutrition/files/ENAcute_Diarrhoea_reprint.pdf. Accessed 2/13/2013.</div>
</li>
<li>
<div class="reference">
                  Corkins MR, Balint J, Bobo E, et al, eds. <i>The A.S.P.E.N Pediatric Nutrition Support Core Curriculum</i>. 2nd ed. Silver Spring: MD: American Society of Parenteral and Enteral Nutrition, 2015.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20195918">
<a name="20195918"></a>de Moraes ML, de Faria Barbosa R, Santo RE, et al, "Maternal-Fetal Distribution of Calcium, Iron, Copper, and Zinc in Pregnant Teenagers and Adults," <i>Biol Trace Elem Res</i>, 2011, 139(2):126-36.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/20195918/pubmed" id="20195918" target="_blank">20195918</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32966722">
<a name="32966722"></a>Dhingra U, Kisenge R, Sudfeld CR, et al. Lower-dose zinc for childhood diarrhea - a randomized, multicenter trial. <i>N Engl J Med</i>. 2020;383(13):1231-1241.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/32966722/pubmed" id="32966722" target="_blank">32966722</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30078716">
<a name="30078716"></a>Domellöf M, Szitanyi P, Simchowitz V, Franz A, Mimouni F; ESPGHAN/ESPEN/ESPR/CSPEN working group on pediatric parenteral nutrition. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Iron and trace minerals. <i>Clin Nutr</i>. 2018;37(6, pt B):2354-2359.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/30078716/pubmed" id="30078716" target="_blank">30078716</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6206098">
<a name="6206098"></a>Foote JW, Delves HT. Albumin bound and alpha 2-macroglobulin bound zinc concentrations in the sera of healthy adults. <i>J Clin Pathol</i>. 1984;37(9):1050‐1054.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/6206098/pubmed" id="6206098" target="_blank">6206098</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11330625">
<a name="11330625"></a>Hotz C, Brown KH. Identifying populations at risk of zinc deficiency: the use of supplementation trials. <i>Nutr Rev</i>. 2001;59(3 Pt 1):80-84.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/11330625/pubmed" id="11330625" target="_blank">11330625</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Institute of Medicine (US) Panel on Micronutrients. <i>Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc</i>. Washington, DC: National Academies Press; 2001. Available at <a href="https://www.ncbi.nlm.nih.gov/books/NBK222310/%20" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK222310/ </a>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19874952">
<a name="19874952"></a>Jeejeebhoy K. Zinc: an essential trace element for parenteral nutrition. <i>Gastroenterology</i>. 2009;137(5 suppl):S7-S12. doi:10.1053/j.gastro.2009.08.014<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/19874952/pubmed" id="19874952" target="_blank">19874952</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Joyce.1">
<a name="Joyce.1"></a>Joyce JC. Nutritional dermatoses. In: Kliegman RM, St. Geme J, eds. <i>Nelson Textbook of Pediatrics</i>. 21st ed. Saunders Elsevier; 2020:chap. 691.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35971347">
<a name="35971347"></a>Kumar M, Nanja Reddy S, Ismail R. Copper and zinc feud: is this myelodysplasia or myelodysplastic syndrome? <i>Cureus</i>. 2022;14(7):e26789. doi:10.7759/cureus.26789<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/35971347/pubmed" id="35971347" target="_blank">35971347</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27996088">
<a name="27996088"></a>Lazzerini M, Wanzira H. Oral zinc for treating diarrhoea in children. <i>Cochrane Database Syst Rev</i>. 2016;12(12):CD005436.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/27996088/pubmed" id="27996088" target="_blank">27996088</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25681484">
<a name="25681484"></a>Livingstone C. Zinc: physiology, deficiency, and parenteral nutrition. <i>Nutr Clin Pract</i>. 2015;30(3):371-382.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/25681484/pubmed" id="25681484" target="_blank">25681484</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18245424">
<a name="18245424"></a>Lukacik M, Thomas RL, Aranda JV. A meta-analysis of the effects of oral zinc in the treatment of acute and persistent diarrhea. <i>Pediatrics</i>. 2008;121(2):326-336.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/18245424/pubmed" id="18245424" target="_blank">18245424</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34484374">
<a name="34484374"></a>Marumo A, Yamamura T, Mizuki T, Tanosaki S, Suzuki K. Copper deficiency-induced pancytopenia after taking an excessive amount of zinc formulation during maintenance hemodialysis. <i>J Res Med Sci</i>. 2021;26:42. doi:10.4103/jrms.JRMS_25_19<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/34484374/pubmed" id="34484374" target="_blank">34484374</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15568296">
<a name="15568296"></a>Mirtallo J, Canada T, Johnson D, et al. Safe practices for parenteral nutrition. <i>JPEN J Parenter Enteral Nutr</i>. 2004; 28(6):S39-70.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/15568296/pubmed" id="15568296" target="_blank">15568296</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NIH.1">
<a name="NIH.1"></a>National Institutes of Health (NIH). Zinc fact sheet for health professionals. <a href="https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/" target="_blank">https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/</a>. Updated September 28, 2022. Accessed November 30, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20141096">
<a name="20141096"></a>Saper RB, Rash R. Zinc: an essential micronutrient. <i>Am Fam Physician</i>. 2009;79(9):768-772.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/20141096/pubmed" id="20141096" target="_blank">20141096</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27933128">
<a name="27933128"></a>Trivedi SS, Chudasama RK, Patel N. Effect of zinc supplementation in children with acute diarrhea: randomized double blind controlled trial. <i>Gastroenterology Res</i>. 2009;2(3):168-174. doi:10.4021/gr2009.06.1298<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/27933128/pubmed" id="27933128" target="_blank">27933128</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23978355">
<a name="23978355"></a>Ubesie AC, Kocoshis SA, Mezoff AG, Henderson CJ, Helmrath MA, Cole CR. Multiple micronutrient deficiencies among patients with intestinal failure during and after transition to enteral nutrition. <i>J Pediatr</i>. 2013;163(6):1692-1696.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/23978355/pubmed" id="23978355" target="_blank">23978355</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22730042">
<a name="22730042"></a>Vanek VW, Borum P, Buchman A, et al; Novel Nutrient Task Force, Parenteral Multi-Vitamin and Multi–Trace Element Working Group; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. <i>Nutr Clin Pract</i>. 2012;27(4):440-491. doi: 10.1177/0884533612446706.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/zinc-sulfate-pediatric-drug-information/abstract-text/22730042/pubmed" id="22730042" target="_blank">22730042</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  World Health Organization (WHO); UNICEF. Clinical management of acute diarrhoea. 2004. Available at: https://www.who.int/maternal_child_adolescent/documents/who_fch_cah_04_7/en/.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ZincSulfate.1">
<a name="ZincSulfate.1"></a>Zinc sulfate injection, USP [prescribing information]. Lake Zurich, IL: Fresenius Kabi; November 2022.</div>
</li>
<li>
<div class="reference">
                  Zinc sulfate tablet [prescribing information]. Brooklyn, NY: Geri-Care Pharmaceuticals; April 2020.</div>
</li></ol></div><div id="topicVersionRevision">Topic 88581 Version 226.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
